[1] WIEGAND J,BERG T.The etiology,diagnosis and prevention of liver cirrhosis:part 1 of a series on liver cirrhosis[J].Dtsch Arztebl Int,2013,110(6):85-91.
|
[2] CHEN XY,YU YY,ZHANG WJ,et al.Effect of antiviral therapy for chronic hepatitis B and related factors[J].China Health Nutrition,2013,23(2):166-170.(in Chinese)陈新月,于岩岩,张文瑾,等.慢性乙型肝炎抗病毒治疗疗效及因素研究[J].中国保健营养,2013,23(2):166-170.
|
[3]NIE QH.Clinical practice of antiviral treatment for liver cirrhosis patients with chronic hepatitis B[J].Chin J Pract Int Med,2014,34(6):568-571.(in Chinese)聂青和.核苷酸类似物药物治疗乙型肝炎肝硬化的临床实践[J].中国实用内科杂志,2014,34(6):568-571.
|
[4]MIN J,ZHONG L,JIN L.Ultrasound findings of alcoholic cirrhosis and post-hepatitis cirrhosis:a comparative analysis[J].Chin Hepatol,2014,12(6):313-313.(in Chinese)闵洁,钟玲,金蕾.酒精性肝硬化与肝炎肝硬化的超声对比[J].肝脏,2014,12(6):313-313.
|
[5]WANG CY,JI D,CHEN GF.Research advances in evaluation and treatment of liver cirrhosis patients with malnutrition[J/CD].Chin J Liver Dis:Electronic Edition,2014,7(3):44-51.(in Chinese)王春艳,纪冬,陈国凤.肝硬化营养不良的评价及治疗的研究进展[J/CD].中国肝脏病杂志:电子版,2014,7(3):44-51.
|
[6] Chinese Society of Hepatology Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J].J Clin Hepatol,2011,27(1):Ⅰ-ⅩⅥ.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].临床肝胆病杂志,2011,27(1):Ⅰ-ⅩⅥ.
|
[7]YANG ZJ.Clinical research of nutrition status investigation in hospitalized liver cirrhosis patients and analysis of nutrition status and prognosis[D].Hefei:Anhui Med Univ,2012.(in Chinese)杨中菊.肝硬化住院患者营养状况调查及与预后分析的临床研究[D].合肥:安徽医科大学,2012.
|
[8]VERLOH N,HAIMERL M,RENNERT J,et al.Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRIat 3 Tesla[J].Eur J Radiol,2013,82(10):1710-1715.
|
[9]LI YY,WANG YR,FANG Y.Nutritional status of patients with decompensated hepatitis B cirrhosis[J].Modern Diagn Treat,2014,11(21):33-41.(in Chinese)李艳艳,王育蓉,方媛.乙肝肝硬化失代偿期患者营养状况分析[J].现代诊断与治疗,2014,11(21):33-41.
|
[10]CAO HX,FAN JG.Nutritional assessment and support treatment of patients with liver cirrhosis[J].J Pract Hepatol,2014,23(5):459-462.(in Chinese)曹海霞,范建高.肝硬化患者营养评估及营养支持治疗[J].实用肝脏病杂志,2014,23(5):459-462.
|
[11]ZHANG SQ,SUN HY.Effect of enteral nutrition therapy in patients with decompensated liver cirrhosis[J].Chin J Hepatol,2013,21(10):769-771.(in Chinese)张淑芹,孙海英.肠道营养干预对失代偿性肝硬化患者营养状况及肝功能的影响[J].中华肝脏病杂志,2013,21(10):769-771.
|
[12]WANG YF.The value of serum prealbumin and total bile acid in the diagnosis of liver cirrhosis classification[J].J Clin Exp Med,2013,12(11):837-838.(in Chinese)王有法.血清前白蛋白和总胆汁酸在诊断肝硬化分级中的价值[J].临床和实验医学杂志,2013,12(11):837-838.
|
[13]HU YQ,WANG ZQ,XU Z.The disorder of blood lipid of patients with liver cirrhosis and its clinic significance[J].Chin J Clin Gastroenterol,2001,13(5):214-216.(in Chinese)胡阳黔,王子强,徐章.肝硬化患者脂质代谢紊乱及其临床意义[J].临床消化病杂志,2001,13(5):214-216.
|
[14]ZHOU YJ,YU ZJ.Nutritional assessment and treatment in patients with liver cirrhosis[J].World Chin J Dig,2014,20(31):4750-4756.(in Chinese)周永健,余祖江.肝硬化患者的营养评价与营养治疗[J].世界华人消化杂志,2014,20(31):4750-4756.
|
[1] | Zhiru WANG, Wenjing ZHAO, Xi CHEN. Effect and mechanism of gallic acid on the proliferation, migration, invasion, and apoptosis of human hepatocellular carcinoma HepG2 cells[J]. Journal of Clinical Hepatology, 2025, 41(3): 493-498. doi: 10.12449/JCH250315 |
[2] | Junzhe CAI, Songbai LIU, Xiaobin FEI, Peng LIU, Changhao ZHU, Xing WANG, Yaozhen PAN. Effect of ankyrin-repeat domain-containing protein 22 on human hepatoma cells and its mechanism[J]. Journal of Clinical Hepatology, 2024, 40(5): 989-996. doi: 10.12449/JCH240519 |
[3] | Lina BAI, Ying LIU, Chunxiao TANG, Hongxin PIAO, Zhenhua LIN, Wanshan YANG, Aihua JIN. Mechanism of carrimycin in regulating the biological function of pancreatic cancer cells[J]. Journal of Clinical Hepatology, 2022, 38(12): 2793-2801. doi: 10.3969/j.issn.1001-5256.2022.12.020 |
[4] | Jianan ZHAO, Jinghua PENG, Ping LIU, Yiyang HU. Effect of Cordyceps polysaccharides on hepatocyte apoptosis induced by tumor necrosis factor-α[J]. Journal of Clinical Hepatology, 2021, 37(6): 1368-1372. doi: 10.3969/j.issn.1001-5256.2021.06.029 |
[5] | Lu Qian, Cheng Xin, Xia ZhenGuo, Chen Zhong. Effect of proteasome subunit beta type 4 on the proliferation and viability of human liver cancer SMMC7721 cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 592-595. doi: 10.3969/j.issn.1001-5256.2020.03.024 |
[6] | Wang ZeXin, Guan LiJun, Li JianMing, Wang ZhiChao, Xue MengRuo, Qin XiaoJun. Effect of targeted regulation of the Wnt2 gene by microRNA( microRNA-21) on the proliferation and migration of HepG2 hepatoma cells[J]. Journal of Clinical Hepatology, 2020, 36(4): 803-807. doi: 10.3969/j.issn.1001-5256.2020.04.019 |
[7] | Xiao ErHui, Ning HuiBin, Kang YueHua, Yin Hui, Ma Li, Mao ZhongShan, Zhao Yan, Shang Jia. Downregulation of miR-196b in regulating the growth and apoptosis of hepatoma cells by targeting nuclear apoptosis-inducing factor 1[J]. Journal of Clinical Hepatology, 2020, 36(10): 2230-2235. doi: 10.3969/j.issn.1001-5256.2020.10.014 |
[8] | Zhang Yang, Chen ShuYing, Xu GuangRu. Effect of extracellular ubiquitin on the proliferation,invasion,and migration of hepatoma cells[J]. Journal of Clinical Hepatology, 2020, 36(6): 1289-1292. doi: 10.3969/j.issn.1001-5256.2020.06.020 |
[9] | Zhu YueKun, Zhao XianQi, Wang DaWei, Zhang Wei, Tian MaoLin, Li ZhengTian, Zhao Long, Li Chao, Jiang HongChi. Effect of cyclooxygenase-2 antisense RNA combined with celecoxib on the proliferation and apoptosis of hepatoma cells[J]. Journal of Clinical Hepatology, 2018, 34(12): 2614-2618. doi: 10.3969/j.issn.1001-5256.2018.12.021 |
[10] | Li YingYing, Zhan LiFen, Ceng ZheChao, Xu Shen. Effect of lobaplatin on proliferation and apoptosis of hepatocellular carcinoma HepG2 cells and related mechanism of action[J]. Journal of Clinical Hepatology, 2018, 34(4): 784-788. doi: 10.3969/j.issn.1001-5256.2018.04.018 |
[11] | Sha Liang, He JianBo, Li KeZhi, Chen Chuang, Huang Shan, Zhao YinNong, Lian Fang, Wu GuoBin. Influence of specific down-regulation of LKB1 expression on invasion and migration of hepatoma cells[J]. Journal of Clinical Hepatology, 2017, 33(5): 875-879. doi: 10.3969/j.issn.1001-5256.2017.05.016 |
[12] | Geng YaJun, Li ShuDong, Liu ShenZheng, Ren JianJun, Zhang Tong. Inhibitory effect of microRNA-149-5p in the proliferation and migration of HepG2 and Bel-7402 hepatoma cells[J]. Journal of Clinical Hepatology, 2017, 33(6): 1126-1130. doi: 10.3969/j.issn.1001-5256.2017.06.022 |
[13] | Zhang ChaoYa, Zhao XiangXuan, Lu ZaiMing, Guo QiYong. Research advances in sorafenib- induced apoptotic signaling pathways in liver cancer cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 816-820. doi: 10.3969/j.issn.1001-5256.2016.04.048 |
[14] | Pan LiuLan, Jia ShengNan, Ma JingTing, Tai JingHua, Jin ZhenJing. Effect of decoy receptor 3 gene on hepatocyte apoptosis[J]. Journal of Clinical Hepatology, 2016, 32(7): 1330-1333. doi: 10.3969/j.issn.1001-5256.2016.07.023 |
[15] | Du SenRong, Mao XiaoRong, Xiao Ping, Chen Hong. Effects of PARP-1 inhibitors AG-014699 and AZD2281 on proliferation and apoptosis of human hepatoma cell line HepG2[J]. Journal of Clinical Hepatology, 2015, 31(6): 943-946. doi: 10.3969/j.issn.1001-5256.2015.06.027 |
[16] | Xu Li, Ma KeXin, Dong Bing, Liu HaiWang, Liu QinLong, Gao ZhenMing, Sun DeGuang, Zhang RiXin, Wang HaiBo, Wang LiMing, Liang Rui. Regulatory effect of miRNAs on apoptosis, migration, and cell cycle of hepatocellular carcinoma cells[J]. Journal of Clinical Hepatology, 2013, 29(7): 554-557. |
[17] | Shen Bo, Nie YuQiang. Peroxisome proliferator- activated receptor gamma inhibits liver cancer proliferation and metastasis in vitro[J]. Journal of Clinical Hepatology, 2013, 29(9): 702-706. doi: 10.3969/j.issn.1001-5256.2013.09.018 |
[18] | Jia XiaoLi, Shi JuanJuan, Feng Ting, Cheng YanAn, Wang Rui, Liu JingKun, Dang ShuangSuo. Effects of guggulsterone on proliferation and apoptosis of HepG2 human hepatocellular carcinoma cells[J]. Journal of Clinical Hepatology, 2013, 29(6): 452-455. |
[19] | Tai BoJun, Yao Min, Gu Xing, Shi Yun, Yu DanDan, Chen Jie, Zheng WenJie, Yao DengFu, Lu ShaoLin. Effects of silencing glypican- 3 gene transcription on proliferation and apoptosis of hepatoma cells[J]. Journal of Clinical Hepatology, 2013, 29(11): 863-866. doi: 10.3969/j.issn.1001-5256.2013.10.015 |
[20] | Qiao ChunPing, Chen YueXiang. Advances in study of the relationship between apoptosis and alcoholic liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 386-390. |
1. | 李慧萍,郑雪琴,赵群,唐建江. Ⅲ型前胶原、Ⅳ型胶原、层黏连蛋白和透明质酸酶在诊断肝纤维化程度中的应用. 检验医学与临床. 2019(05): 666-668 . ![]() | |
2. | 吴一鸣,高树兴,殷新光. 核素首次通过法测定肝动脉血流指数预测日本血吸虫病肝纤维化程度?. 中国肝脏病杂志(电子版). 2018(02): 49-54 . ![]() | |
3. | 柯叶芳,高国生,朱喆,陈必成. 血清腺苷脱氨酶对慢性HBV感染者显著肝纤维化的诊断价值. 临床肝胆病杂志. 2018(04): 760-763 . ![]() | |
4. | 吴一鸣,高树兴,殷新光. 测定肝动脉血流指数预测血吸虫肝纤维化的临床研究. 世界华人消化杂志. 2018(07): 434-440 . ![]() | |
5. | 胡烨,张国. 肝纤维化诊断及其严重程度评估. 实用肝脏病杂志. 2017(01): 13-16 . ![]() | |
6. | 王娉娉,杨芬. 生物组织弹性成像方法及其新技术进展. 激光生物学报. 2016(06): 501-508+514 . ![]() | |
7. | 牟文倩,李春艳,陈延平. 继发性血色病1例报告. 临床肝胆病杂志. 2016(09): 1789-1790 . ![]() |